Cargando…
Chikungunya Virus
For chikungunya virus (CHIKV), the long-term sequelae from infection are yet ill-defined. The prolonged debilitating arthralgia associated with CHIKV infection has tremendous potential for impacting the global economy and should be considered when evaluating the human burden of disease and the alloc...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469677/ https://www.ncbi.nlm.nih.gov/pubmed/28457355 http://dx.doi.org/10.1016/j.cll.2017.01.008 |
_version_ | 1783243625149235200 |
---|---|
author | Vu, David M. Jungkind, Donald Angelle Desiree LaBeaud |
author_facet | Vu, David M. Jungkind, Donald Angelle Desiree LaBeaud |
author_sort | Vu, David M. |
collection | PubMed |
description | For chikungunya virus (CHIKV), the long-term sequelae from infection are yet ill-defined. The prolonged debilitating arthralgia associated with CHIKV infection has tremendous potential for impacting the global economy and should be considered when evaluating the human burden of disease and the allocation of resources. There is much still unknown about CHIKV and the illnesses that it causes. Developing a better understanding of the pathogenesis of CHIKV infection is a priority and forms the basis for developing effective strategies at infection prevention and disease control. |
format | Online Article Text |
id | pubmed-5469677 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-54696772018-06-01 Chikungunya Virus Vu, David M. Jungkind, Donald Angelle Desiree LaBeaud Clin Lab Med Article For chikungunya virus (CHIKV), the long-term sequelae from infection are yet ill-defined. The prolonged debilitating arthralgia associated with CHIKV infection has tremendous potential for impacting the global economy and should be considered when evaluating the human burden of disease and the allocation of resources. There is much still unknown about CHIKV and the illnesses that it causes. Developing a better understanding of the pathogenesis of CHIKV infection is a priority and forms the basis for developing effective strategies at infection prevention and disease control. Elsevier Inc. 2017-06 2017-03-27 /pmc/articles/PMC5469677/ /pubmed/28457355 http://dx.doi.org/10.1016/j.cll.2017.01.008 Text en © 2017 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Vu, David M. Jungkind, Donald Angelle Desiree LaBeaud Chikungunya Virus |
title | Chikungunya Virus |
title_full | Chikungunya Virus |
title_fullStr | Chikungunya Virus |
title_full_unstemmed | Chikungunya Virus |
title_short | Chikungunya Virus |
title_sort | chikungunya virus |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469677/ https://www.ncbi.nlm.nih.gov/pubmed/28457355 http://dx.doi.org/10.1016/j.cll.2017.01.008 |
work_keys_str_mv | AT vudavidm chikungunyavirus AT jungkinddonald chikungunyavirus AT angelledesireelabeaud chikungunyavirus |